Katja van den Hurk: Using Mean Hemoglobin to Improve Donor Eligibility
Katja van den Hurk, Head of Donor Studies at Sanquin, reposted from Amber Meulenbeld on LinkedIn:
”Excited to share our latest work on an alternative deferral algorithm based on mean haemoglobin (Hb) levels), a first step toward a more comprehensive and data-driven assessment of donor eligibility.
Our findings suggest that using historical mean Hb to guide donor deferral decisions could reduce Hb deferral rates and may also help to prevent donations from donors with consistently low Hb levels.
However, this is only the beginning: Further studies are crucial to understand whether donors identified by this algorithm can indeed donate safely under these circumstances. Future work will refine the model, integrate data on iron stores and recovery as well as donor characteristics, and evaluate long-term donor health outcomes.
I am proud to contribute to this international collaborative effort, very efficiently done by Amber Meulenbeld, in memory of Mart Janssen, aimed at enhancing both donor safety and blood supply sustainability.”
Quoting Amber Meulenbeld‘s post:
”If Hb deferral rates are a challenge in your blood establishment, our new study offers a promising new approach! Just published open access in Vox Sanguinis.
By using historical mean Hb levels to assess donor eligibility, we found that deferral rates could drop by up to 70%.
This method also flags donors with consistently low Hb levels who currently pass eligibility due to one-off high readings. That’s a potential safety issue we should start addressing.
This is an early but important step toward incorporating individual histories in donor screening, and I’m curious to see how this develops further!
Another fruitful collaboration of the SanguinStats group, with special thanks to Claire Styles, Glen Shuttleworth, Supun Manathunga, Hans Van Remoortel, Lucile Malard, Tinus Brits, Ronel Swanevelder, José Antonio García Erce, Iris Garcia-Martínez, Surendra Karki (PhD, Epidemiology), Marijke Welvaert, Alton Russell, PhD, Mikko Arvas, Katja van den Hurk, Mart Pothast, and Mart Janssen.”
Title: Potential benefits of an alternative haemoglobin deferral strategy evaluated in seven countries
Authors: Amber Meulenbeld, Claire Styles, Glen Shuttleworth, Supun Manathunga, Hans van Remoortel, Lucile Malard, Tinus Brits, Ronel Swanevelder, Jose Antonio García-Erce, Iris Garcia-Martínez, Surendra Karki, Marijke Welvaert, W. Alton Russell, Mikko Arvas, Katja van den Hurk, Mart Pothast, Mart Janssen
Read the full article here.
Stay updated with Hemostasis Today.
-
Oct 30, 2025, 03:53Michael Makris on Biomarin's Decision to Divest Roctavian
-
Oct 29, 2025, 10:39UMR1011 Researchers at ECTH 2025
-
Oct 29, 2025, 07:09Hritvik Jain and Andrew Goldsweig Sharedrisk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
-
Oct 29, 2025, 07:07Flora Peyvandi Shared an Article About Menstrual Bleeding and Bleeding Tendency in Dutch Adolescents
-
Oct 29, 2025, 07:04Joana Williams: How Sickle Cell Trait Protects Against Malaria
-
Oct 29, 2025, 07:18Osimertinib Has Transformed Lung Cancer Care — But at What Cost to the Heart?
-
Oct 29, 2025, 07:15From the Lab to Prague․ Our ECTH 2025 Experience
-
Oct 29, 2025, 07:13Amol Akhade: Happy To Share Our Paper Published In Lancet Oncology
-
Oct 29, 2025, 07:09Davide Capodanno: This Time It’s About the Timing of Complete Revascularization in ACS
-
Oct 29, 2025, 04:00Markus Bender Authores A Chapter in ''Platelets in Disease: Hemorrhagic Disorders''
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Oct 27, 2025, 09:19Mitra Najafi: Digital Storage Device - Specifically Designed and Developed to Store and Preserve PRP
-
Oct 30, 2025, 03:50Laura Bouvet Receives the Young Investigator Award at ECTH 2025
-
Oct 29, 2025, 08:30ECTH 2025․ Advancing the Science of Thrombosis and Haemostasis Together
-
Oct 28, 2025, 06:59Wim van den Broek Attended ECTH in Prague
-
Oct 28, 2025, 06:46Alexandre Kauskot Attended ECTH in Prague
-
Oct 28, 2025, 06:45Lihi Schwartz Presented Efficacy and Safety of Anticoagulation for Subsegmental Pulmonary Embolism